To identify key epigenetic regulators of acute myeloid leukemia (AML) cell fate, researchers performed a differentiation-focused CRISPR screen in AML cells, which identified the histone acetyltransferase KAT6A as a novel regulator of myeloid differentiation that drives critical leukemogenic gene expression programs.
[Cancer Discovery]
Sorry, but the selected Zotpress account can't be found.
